About Alliqua
Alliqua is a company based in Yardley (United States) founded in 1997. Alliqua has completed 2 acquisitions, including Celleration and Choice Therapeutics. Alliqua offers products and services including Custom Hydrogels and Hydrogel Manufacturing Platform. Alliqua operates in a competitive market with competitors including scPharmaceuticals, Crossject, Valeritas, CeQur and Vaxxas, among others.
- Headquarter Yardley, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Alliqua Biomedical, Inc.
-
Annual Revenue
$2.22 M (USD)10as on Dec 31, 2018
-
Net Profit
-$8.42 M (USD)67as on Dec 31, 2018
-
EBITDA
-$5.3 M (USD)-11as on Dec 31, 2018
-
Latest Funding Round
$2.77 M (USD), Post-IPO
Mar 13, 2017
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Celleration
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alliqua
Alliqua offers a comprehensive portfolio of products and services, including Custom Hydrogels and Hydrogel Manufacturing Platform.
Hydrogels for wound healing and skin care delivery
Platform for electron-beam cross-linked gels in healthcare
People of Alliqua
Unlock access to complete
Unlock access to complete
Funding Insights of Alliqua
Investors in Alliqua
Alliqua has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Perceptive Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Locked | Locked | Locked |
Investor details for Alliqua
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Alliqua
Alliqua has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Celleration and Choice Therapeutics.
Investment portfolio details for Alliqua
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Wound care products for burns and surgical infections are manufactured.
|
Locked | Locked | 2006 | Locked | |
|
Ultrasound technology for wound healing is developed and marketed.
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for Alliqua
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Alliqua
Detailed financials for Alliqua
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alliqua Comparisons
Peer comparison for Alliqua
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Alliqua
Alliqua operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as scPharmaceuticals, Crossject, Valeritas, CeQur and Vaxxas, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of a device for subcutaneous drug delivery for the treatment of bacterial infections and heart failure
|
|
| Locked | Locked | Locked |
Needle-free self-injectable drugs
|
|
| Locked | Locked | Locked |
Wearable insulin patch pumps are developed for transdermal delivery.
|
|
| Locked | Locked | Locked |
Wearable insulin delivery patches are developed for mealtime dosing.
|
|
| Locked | Locked | Locked |
Developer of vaccines to treat cancer and infectious diseases
|
|
| Locked | Locked | Locked |
Hospital-focused specialty pharmaceuticals are developed for acute pain management.
|
Detailed competitors of Alliqua
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alliqua
Complete news archive for Alliqua
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alliqua
Alliqua was founded in 1997 and raised its 1st funding round 13 years after it was founded.
Alliqua is headquartered in Yardley, United States. It is registered at Yardley, Pennsylvania, United States.
Annual revenue of Alliqua is $2.22M as on Dec 31, 2018.
Alliqua was founded in 1997 as a biomedical company based in Yardley, United States. Operations focus on the development, manufacturing, and marketing of proprietary wound care products, including SilverSeal Hydrogel for antimicrobial applications and Hydress for moist wound management. A core transdermal delivery platform is utilized to enable drug and ingredient absorption through the skin, supporting advancements in the healthcare sector.
Alliqua's top competitors include scPharmaceuticals, Crossject and Vaxxas.
Alliqua offers Custom Hydrogels and Hydrogel Manufacturing Platform.
Alliqua has made 2 acquisitions, including Celleration, and Choice Therapeutics.
Alliqua has 1 investor. Key investors include Perceptive Advisors.